Progesterone (micronised) is indicated in women for supplementation of the luteal phase during ART cycles.
|NCPE Assessment Process||Complete|
|Rapid review commissioned||14/10/2019|
|Rapid review completed||20/11/2019|
|Rapid Review outcome||A full HTA is not recommended. The NCPE recommends that progesterone (micronised) be considered for reimbursement.*|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.